Renaissance Technologies’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$104K Buy
+10,200
New +$104K ﹤0.01% 3294
2024
Q4
Sell
-13,700
Closed -$140K 3813
2024
Q3
$140K Sell
13,700
-33,300
-71% -$341K ﹤0.01% 3197
2024
Q2
$332K Sell
47,000
-63,900
-58% -$452K ﹤0.01% 2868
2024
Q1
$1.53M Sell
110,900
-77,600
-41% -$1.07M ﹤0.01% 2211
2023
Q4
$1.73M Sell
188,500
-191,300
-50% -$1.76M ﹤0.01% 2044
2023
Q3
$2.3M Buy
379,800
+36,100
+11% +$218K ﹤0.01% 1774
2023
Q2
$2.67M Sell
343,700
-400
-0.1% -$3.1K ﹤0.01% 1818
2023
Q1
$1.96M Buy
344,100
+27,300
+9% +$156K ﹤0.01% 2040
2022
Q4
$1.87M Sell
316,800
-84,600
-21% -$498K ﹤0.01% 2113
2022
Q3
$1.28M Sell
401,400
-46,469
-10% -$149K ﹤0.01% 2345
2022
Q2
$2.01M Buy
447,869
+228,769
+104% +$1.02M ﹤0.01% 2193
2022
Q1
$1.17M Buy
219,100
+192,800
+733% +$1.03M ﹤0.01% 2629
2021
Q4
$387K Buy
+26,300
New +$387K ﹤0.01% 3209